Published in:
01-02-2005 | Letters to the Editor
It Is Still Not the Time to Change Surgical Strategy for Gastric Cancer
To the Editor
Author:
Wei-Jei Lee, MD, PhD
Published in:
Annals of Surgical Oncology
|
Issue 2/2005
Login to get access
Excerpt
I read with interest the editorial by Kappas et al.
1 The author advocates the application of gastrectomy with D2 lymph node dissection for gastric cancer resection. The recommendation is based on long-term survival findings in the Dutch trial.
2 There was a 20% long-term survival rate among N2 patients who had undergone D2 dissection, versus 0% among those who had a D1 resection in the Dutch trial. From these data, the author estimated an overall absolute survival benefit of approximately 6% (30% N2 incidence; 20% N2 survivors) for routine D2 dissection in all patients with curable disease. However, the analysis in the Dutch trial is inappropriate, and the estimation by the author is incorrect. …